(:CLXT)

Business Focus: N/A

May 19, 2023 04:01 pm ET

Calyxt Announces Stockholder Approval of Merger With Cibus

-- Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock --

May 01, 2023 04:01 pm ET

Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update

—Proposed merger with Cibus Global Expected to Close in Q2 2023—

Apr 24, 2023 04:35 pm ET

Calyxt Completes One-for-Ten Reverse Stock Split

ROSEVILLE, Minn., April 24, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announced that it has completed the previously announced reverse stock split of Calyxt's common stock, par value $0.0001 per share ("Common Stock"), at a ratio of 1-for-10. The reverse stock split was previously approved by the Company's stockholders at the annual meeting of shareholders on June 1, 2022.

Apr 18, 2023 04:05 pm ET

Calyxt, Inc. Announces Effectiveness of Registration Statement on Form S-4 in Connection with Merger with Cibus Global LLC

ROSEVILLE, Minn. and SAN DIEGO, April 18, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, today announced that the registration statement on Form S-4, initially filed with the U.S. Securities and Exchange Commission ("SEC") by Calyxt on February 14, 2023, and amended on April 14, 2023 (as amended, the "Registration Statement"), has been declared effective by the SEC.

Apr 07, 2023 04:05 pm ET

Calyxt Announces Effective Date of Reverse Stock Split

ROSEVILLE, Minn., April 7, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announced that it will proceed with the 1-for-10 reverse stock split previously approved by the Company's shareholders at the annual meeting of shareholders on June 1, 2022. Calyxt plans to file an amendment to its certificate of incorporation to effectuate the reverse stock split after the close of trading on April 24, 2023, and Calyxt's common stock, par value $0.0001 per share, will begin trading on an adjusted basis giving effect to the reverse stock split on April 25, 2023.

Mar 12, 2023 11:33 am ET

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AQUA, GMGI, INFI, CLXT

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Evoqua Water Technologies Corp. (NYSE:...

Mar 09, 2023 09:08 pm ET

CALYXT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Calyxt, Inc. - CLXT

NEW ORLEANS, March 9, 2023 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Calyxt, Inc. ("the Company") (NasdaqCM: CLXT) with Cibus pursuant to which Calyxt shareholders will own approximately 5% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

Mar 06, 2023 04:30 pm ET

Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update

Cellectis S.A. (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that Calyxt, Inc. (Nasdaq: CLXT), a...

Jan 21, 2023 08:11 pm ET

Lifshitz Law PLLC Announces Investigations of GMGI, ANGN, CLXT, and VLTA

Golden Matrix Group, Inc. (NASDAQ: GMGI) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of GMGI and MeridianBet Group. If you are a GMGI investor, and would like additional...

Jan 20, 2023 07:00 am ET

SHAREHOLDER ALERT: Weiss Law Reminds CLXT, BRBW, MPB, and COUP Shareholders About Its Ongoing Investigations

NEW YORK, Jan. 20, 2023 /PRNewswire/ --

Jan 19, 2023 11:50 am ET

CALYXT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Calyxt, Inc. - CLXT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Calyxt, Inc. (“the Company”) (NasdaqCM: CLXT) with Cibus pursuant to which Calyxt shareholders will own approximately 5% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company.

Jan 19, 2023 09:50 am ET

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CBIO, HZN, CLXT, VLTA

NEW YORK, Jan. 19, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Jan 18, 2023 04:51 pm ET

ALERT: The M&A Class Action Firm Announces the Investigation of Calyxt, Inc. - CLXT

NEW YORK, Jan. 18, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Calyxt, Inc. (NASDAQ: CLXT), relating to its proposed merger with Cibus. Under the terms of the agreement, Cibus shareholders are expected to receive new shares of CLXT, with CLXT shareholders expected to own approximately 5% of the combi

Jan 18, 2023 06:16 am ET

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CLXT, TIG, ANGN

Jan 17, 2023 11:43 pm ET

Shareholder Alert: Ademi LLP investigates whether Calyxt, Inc. has entered into a Fair Transaction with Cibus

MILWAUKEE, Jan. 18, 2023 /PRNewswire/ -- Ademi LLP is investigating Calyxt (Nasdaq: CLXT) for possible breaches of fiduciary duty and other violations of law in its transaction with Cibus.

Jan 17, 2023 09:00 pm ET

SHAREHOLDER ALERT: Weiss Law Investigates Calyxt, Inc.

NEW YORK, Jan. 17, 2023 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Calyxt, Inc. ("Calyxt" or the "Company") (NASDAQ: CLXT), in connection with the proposed acquisition of the Company by Cibus ("Cibus"). Under the terms of the merger agreement, the Company will issue shares of its common stock to Cibus shareholders in an exchange ratio such that upon completion of the merger, Calyxt shareholders will only own approximately 5% of the newly combined company while Cibus shareholders will own 95%.

Jan 17, 2023 11:02 am ET

Thinking about buying stock in Celyad Oncology, Calyxt, IQIYI, Vinco Ventures, or Carvana?

NEW YORK, Jan. 17, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CYAD, CLXT, IQ, BBIG, and CVNA.

Jan 17, 2023 07:27 am ET

CLXT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Calyxt, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Calyxt, Inc. (NASDAQ: CLXT) and Cibus is fair to Calyxt shareholders. Under the terms of the merger agreement, Calyxt will issue shares of its common stock to Cibus shareholders in an exchange ratio such that upon completion of the merger, Calyxt shareholders will own approximately 5% of the combined company.

Jan 17, 2023 07:10 am ET

Calyxt and Cibus Announce the Signing of a Definitive Merger Agreement

Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its gene editing platform to deliver life-saving cell and gene therapies, announced today that Cibus Global LLC, a Delaware limited liability company...

Jan 17, 2023 05:30 am ET

Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company

– The merger will bring together the technology platforms and facilities of two pioneering companies to create a leader in precision gene editing focused on driving sustainable agriculture and the availability of renewable low-carbon ingredients –

Nov 18, 2022 10:00 am ET

Calyxt Achieves Phase 1 Milestone in Collaboration Agreement to Develop Alternative to Palm Oil

ROSEVILLE, Minn., Nov. 18, 2022 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biology company announced today that it has successfully completed the first phase in its research collaboration agreement with a leading global food ingredient manufacturer based in Asia to develop an improved soybean capable of producing an oil as a commercial alternative to palm oil.

Nov 17, 2022 03:01 pm ET

Calyxt Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule

ROSEVILLE, Minn., Nov. 17, 2022 /PRNewswire/ -- Calyxt, Inc (Nasdaq: CLXT) a plant-based synthetic biology focused on engineering sustainable ingredients for customers in the cosmeceutical, nutraceutical and pharmaceutical industries, today announced that the Company received written notification from the Listing Qualifications Department of The Nasdaq Stock Market, LLC ("Nasdaq"), granting the Company's request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Bid Price Rule"). The Company now has until May 15

Nov 03, 2022 04:01 pm ET

Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update

—Successfully produced squalene, an important ingredient for personal care products and vaccine adjuvants—

Nov 01, 2022 07:00 am ET

Calyxt Joins Bioindustrial Manufacturing and Design Ecosystem (BioMADE), a Department of Defense Initiative, to Advance Sustainable Plant-Based Biomanufacturing

-Calyxt joins a select network of synthetic biology companies, top-tier academic institutions, research-focused not-for-profits, and US government agencies dedicated to innovating and growing the bioeconomy-

Oct 27, 2022 07:00 am ET

Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time

ROSEVILLE, Minn., Oct. 27, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, November 3, 2022, at 4:30 p.m. ET to discuss results for the third quarter ended September 30, 2022. A press release detailing these results will be issued prior to the call.

Oct 25, 2022 07:00 am ET

Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants

ROSEVILLE, Minn., Oct. 25, 2022 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biology company, announced today that using a Calyxt-engineered Plant Cell Matrix™ biomass, it has successfully produced squalene, an important ingredient in many personal care products and vaccine adjuvants, including several strands of flu and COVID-19 vaccines.

Oct 06, 2022 07:00 am ET

Calyxt Announces Agreement with Evologic Technologies to Scale Production of its Plant-based Ingredients

Agreement will power speed-to-scale strategy to meet the growing interest in high-quality sustainable ingredients across the cosmeceutical, nutraceutical and pharmaceutical markets

Sep 22, 2022 07:00 am ET

Calyxt, Inc. Exploring Strategic Alternatives

ROSEVILLE, Minn., Sept. 22, 2022 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT) ("Calyxt"), a plant-based synthetic biology company, today announced that its Board of Directors is evaluating potential strategic alternatives to maximize shareholder value. As part of the process, the Board is considering a full range of strategic alternatives, which may include financing alternatives, merger, reverse merger, other business combinations, sale of assets, licensing, or other transactions. Calyxt has retained Canaccord Genuity as its financial advisor and Sidley Austin as its legal counsel to assist

Sep 07, 2022 07:00 am ET

Calyxt to Present at the H.C. Wainwright 24th Annual Global Investment Conference

ROSEVILLE, Minn., Sept. 7, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, President and Chief Executive Officer, and Bill Koschak, Chief Financial Officer, will present at the H.C Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022.

Aug 04, 2022 04:01 pm ET

Calyxt Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Evaluated nine new customer demand-driven plant-based chemistries in the quarter, bringing cumulative chemistries evaluated for development to 95, of these 31 meet Calyxt's target profile and several are the subject of term sheet discussions

Jul 28, 2022 07:00 am ET

Calyxt to Present at the Canaccord Genuity 42nd Annual Growth Conference

ROSEVILLE, Minn., July 28, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, Chief Executive Officer, and Bill Koschak, Chief Financial Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference taking place August 8-11, 2022.

Jul 21, 2022 07:00 am ET

Calyxt to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time

ROSEVILLE, Minn., July 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, August 4, 2022, at 4:30 p.m. Eastern Time to discuss results for the second quarter ended June 30, 2022. A press release detailing these results will be issued prior to the call.

May 17, 2022 07:00 am ET

Calyxt to Present at Upcoming Conferences

ROSEVILLE, Minn., May 17, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that management will participate in the following upcoming investor conferences:

May 05, 2022 04:01 pm ET

Calyxt Reports First Quarter 2022 Financial Results

Achieved technical BioFactory™ and AIML milestones to support customer demand-driven molecule development at scale

Apr 26, 2022 07:00 am ET

Calyxt Announces Strategic Hires in Business Development and Manufacturing

Continued investment in key hires to strategically position Company for future growth and scale

Apr 21, 2022 07:08 am ET

Calyxt to Host First Quarter 2022 Financial Results Conference Call and Webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time

ROSEVILLE, Minn., April 21, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will host a conference call and webcast on Thursday, May 5, 2022, at 4:30 p.m. Eastern Time to discuss results for the first quarter ended March 31, 2022. A press release detailing these results will be issued prior to the call.

Mar 08, 2022 06:00 am ET

Calyxt to Participate in Fireside Chat at the 34th Annual Roth Conference

ROSEVILLE, Minn., March 8, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that management will participate in a fireside chat at the 34th Annual Roth Conference at the Ritz-Carlton in Dana Point, CA.

Mar 03, 2022 03:01 pm ET

Calyxt Reports Fourth Quarter and Full Year 2021 Financial Results

ROSEVILLE, Minn., March 3, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced financial results for its fourth quarter and full year ended December 31, 2021.

Feb 24, 2022 06:00 am ET

Calyxt to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Thursday, March 3, 2022, at 4:30 p.m. Eastern Time

ROSEVILLE, Minn., Feb. 24, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, will hold a conference call on Thursday, March 3, 2022, at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year ended December 31, 2021. A press release detailing these results will be issued prior to the call.

Feb 23, 2022 03:05 pm ET

Calyxt Announces Closing of SEC-Registered Offering of Common Stock, Pre-Funded Warrants to Purchase Common Stock and Warrants to Purchase Common Stock

ROSEVILLE, Minn., Feb. 23, 2022 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT) ("Calyxt" or the "Company"), a plant-based synthetic biology company, today announced the closing of its previously announced placement to an institutional investor in an underwritten offering of 3,880,000 shares of its common stock, pre-funded warrants to purchase up to 3,880,000 shares of its common stock, and common warrants to purchase up to 7,760,000 shares of its common stock (the "Offering").

Feb 18, 2022 04:40 pm ET

Calyxt Announces Pricing of Offering Of Common Stock and Warrants and Updates Business and Risk Factor Disclosure

Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, and Calyxt, Inc. (“Calyxt”), a majority-owned (61.8% as of December...

Feb 17, 2022 07:02 pm ET

Calxyt, Inc. Announces Pricing of $10.9 Million SEC-Registered Offering of Common Stock and Warrants

ROSEVILLE, Minn., Feb. 17, 2022 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT) ("Calyxt" or the "Company"), a plant-based synthetic biology company, today announced the placement to an institutional investor in an underwritten offering of 3,880,000 shares of its common stock, pre-funded warrants to purchase up to 3,880,000 shares of its common stock, and common warrants to purchase up to 7,760,000 shares of its common stock (the "Offering"). The shares of common stock and the pre-funded warrants are each being sold in combination with corresponding common warrants, with one common warrant to pu

Feb 07, 2022 06:00 am ET

Calyxt Announces Gerry Nuovo as Senior Vice President of Business Development

ROSEVILLE, Minn., Feb. 7, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that Gerry Nuovo has joined Calyxt as Senior Vice President of Business Development. He brings more than 30 years of experience in the specialty chemicals and biotechnology industries and diverse experience building multimillion-dollar income streams in the personal care and home care markets. Mr. Nuovo will be responsible for business development functions, including potential partnerships, deal structures, valuation models, and subsequent transaction ex

Jan 06, 2022 04:25 pm ET

Calyxt Announces Pilot BioFactory™ Production System Now Operational

ROSEVILLE, Minn., Jan. 6, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that its pilot BioFactory™ production system, installed in late December 2021, is now operational at its headquarters site in Minnesota.

Jan 04, 2022 06:00 am ET

Calyxt to Present at the H.C. Wainwright BioConnect Virtual Conference

ROSEVILLE, Minn., Jan. 4, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company today announced that a presentation given by management at the H.C Wainwright BioConnect Conference will be available for viewing online on Monday, January 10, 2022 at 7:00 a.m. ET. The conference will be held in a virtual meeting format.

Dec 08, 2021 06:00 am ET

Calyxt Identifies More Than 15,000 Unique Chemical Signatures in Lab-Scale BioFactory™ Production Run

ROSEVILLE, Minn., Dec. 8, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the completion of a key milestone in its lab-scale BioFactory™ manufacturing system. The results identified through the Company's metabolomics analyses indicate over 15,000 chemical signatures, including both known and as-yet-uncharacterized molecules and building block precursors, chemical compounds involved in chemical reactions that produce other compounds. These chemical signatures form a baseline library available for Calyxt to produce valuable compo

Dec 06, 2021 06:00 am ET

Calyxt Announces Strategic Hires in AI/ML and Technology Licensing

ROSEVILLE, Minn., Dec. 6, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the hiring of two senior roles important to furthering Calyxt's recently announced strategic direction. Joining the Company are Vijay Gullapalli, Ph.D., as Vice President, Artificial Intelligence/Machine Learning (AI/ML) and Data Science, reporting to Travis Frey, Ph.D., Chief Technology Officer; and Pete Ball as Technology Licensing Leader, reporting to Debra Frimerman, General Counsel and Corporate Secretary.

Nov 23, 2021 06:00 am ET

Calyxt to Present at the 2021 Canaccord Genuity AgriFood Tech Innovation Virtual Forum

ROSEVILLE, Minn., Nov. 23, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced that management will present at the 2021 Canaccord Genuity AgriFood Tech Innovation Virtual Forum.

Nov 04, 2021 04:01 pm ET

Calyxt Reports Third Quarter 2021 Financial Results

ROSEVILLE, Minn., Nov. 4, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based synthetic biotechnology company, today announced financial results for its third quarter ended September 30, 2021.

Oct 19, 2021 07:00 am ET

Calyxt to Host third Quarter 2021 Financial Results Conference Call on Thursday, November 4, 2021, at 4:30 p.m. Eastern Time

ROSEVILLE, Minn., Oct. 19, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) will hold a conference call on Thursday, November 4, 2021, at 4:30 p.m. Eastern time to discuss its results for the third quarter ended on September 30, 2021. A press release detailing these results will be issued prior to the call.

Oct 12, 2021 07:00 am ET

Calyxt Names IBM's Global Chief Artificial Intelligence Officer, Dr. Seth Dobrin, to Scientific Advisory Board

ROSEVILLE, Minn., Oct. 12, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the appointment of Seth Dobrin, Ph.D., to the Company's Scientific Advisory Board (SAB). Dr. Dobrin is the Global Chief Artificial Intelligence (AI) Officer at IBM and brings extensive leadership experience and a track record of transforming companies through data and AI.

Oct 05, 2021 04:01 pm ET

Calyxt Announces New Strategic Direction to Provide Sustainable, Plant-Based Synthetic Biology Solutions to Expanded Group of End Markets and Diversified Base of Customers

ROSEVILLE, Minn., Oct. 5, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biotechnology company, today announced the launch of a strategic initiative that will focus the Company on engineering synthetic biology solutions for a diversified base of customers across an expanded group of end markets including the nutraceutical, cosmeceutical, pharmaceutical, advanced materials, and chemical industries.

Sep 28, 2021 07:00 am ET

Calyxt Announces Collaboration with Leading Global Food Ingredient Manufacturer to Develop Palm Oil Alternative

ROSEVILLE, Minn., Sept. 28, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based technology platform company, today announced it entered into a research collaboration with a leading global food ingredient manufacturer based in Asia to develop an improved soybean capable of producing an oil as a commercial alternative to palm oil. In addition to the potential health benefits, this soybean and its oil may address sustainability challenges associated with palm oil, such as food miles and palm oil's impact on biodiversity.

Sep 07, 2021 07:30 am ET

Calyxt to Present at the H.C Wainwright 23rd Annual Global Investment Conference

ROSEVILLE, Minn., Sept. 7, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology platform company, today announced that a presentation given by management at the H.C Wainwright 23rd Annual Global Investment Conference will be available for viewing online on September 13th at 7:00 a.m. ET. The conference will be held in a virtual meeting format.

Aug 05, 2021 04:01 pm ET

Calyxt Reports Second Quarter 2021 Financial Results

ROSEVILLE, Minn., Aug. 5, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, today announced financial results for its second quarter ended June 30, 2021.

Aug 04, 2021 08:31 am ET

Calyxt to Present at the Canaccord Genuity 41st Annual Growth Conference on August 11, 2021

ROSEVILLE, Minn., Aug. 4, 2021 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based biotechnology platform company, today announced that management will present at the Canaccord Genuity 41st Annual Growth Conference at 11:00 a.m. ET. The conference will be held in a virtual meeting format.

Jul 27, 2021 04:01 pm ET

Calyxt Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

ROSEVILLE, Minn., July 27, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced that, in accordance with the offer letter entered into on July 15, 2021, it has granted, effective July 27, 2021 (the "Grant Date"), an inducement award to Michael A. Carr, Calyxt's newly appointed President and Chief Executive Officer.

Jul 19, 2021 04:30 pm ET

Calyxt to Host Second Quarter 2021 Financial Results Conference Call on Thursday, August 5, 2021 at 4:30 p.m. Eastern Time

ROSEVILLE, Minn., July 19, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT) will hold a conference call on Thursday, August 5, 2021 at 4:30 p.m. Eastern time to discuss its results for the second quarter ended on June 30, 2021. A press release detailing these results will be issued prior to the call.

Jul 15, 2021 04:01 pm ET

Calyxt Appoints Michael A. Carr as Chief Executive Officer

ROSEVILLE, Minn., July 15, 2021 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced the appointment of Michael A. Carr as President and Chief Executive Officer, effective July 27, 2021. Mr. Carr will also serve as a member of Calyxt's Board of Directors. Mr. Carr was most recently the Vice President of M&A, Strategy, and Innovation at Darling Ingredients, Inc., a global developer and producer of sustainable natural ingredients and renewable energy.

Jul 08, 2021 08:31 am ET

Calyxt Announces Expansion of Hemp Breeding Platform with Seedless Hemp Innovation

Triploid Breeding Process is Calyxt's Second Announced Advancement and Part of a Comprehensive Approach to Improving Hemp Genetics

May 06, 2021 04:01 pm ET

Calyxt Reports First Quarter 2021 Financial Results

ROSEVILLE, MN / ACCESSWIRE / May 6, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, today announced financial results for its first quarter ended March 31, 2021.

May 04, 2021 08:31 am ET

Calyxt Announces Next Generation Premium Soybean Product Line Performance Best-In-Class for High Oleic, Ultra-Low Linolenic Profile

ROSEVILLE, MN / ACCESSWIRE / May 4, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, announced today that its next generation premium high oleic low linolenic (HOLL) soybean oil trait has exceeded industry performance targets expected in the premium oil segment. This marks a step-improvement on Calyxt's first gene-edited product that was commercialized in the U.S. by delivering superior functional performance plus a -superior functional performance and fatty acid profile superior to other premium oils.

Apr 29, 2021 08:31 am ET

Calyxt Successfully Transforms Hemp Genome

New Hemp Transformation Technology Unlocks Capabilities to Selectively Breed and Deliver Improvements in Hemp Traits for Key Markets Including Protein, Fiber, Advanced Materials and Wellness Patent-Pending Transformation Process is Calyxt's First Announced Innovation in a Broad Hemp Improvement Pipeline

Apr 20, 2021 08:31 am ET

Calyxt to Present at Upcoming Investor and Industry Conferences

ROSEVILLE, MN / ACCESSWIRE / April 20, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, will participate in the following investor and industry conferences during the month of May 2021:

Apr 15, 2021 08:31 am ET

Calyxt to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 6, 2021 at 4:30 p.m. Eastern Time

Mar 04, 2021 04:01 pm ET

Calyxt Reports Fourth Quarter and Full Year 2020 Financial Results

Continued to Progress Development of Winter Oats and Hemp, Both Targeted at Large Addressable Markets

Mar 03, 2021 08:31 am ET

Calyxt to Present at Upcoming March Investor Conferences

ROSEVILLE, MN / ACCESSWIRE / March 3, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, will participate in the following investor conferences during the month of March 2021:

Mar 02, 2021 08:31 am ET

Calyxt Completes New Scientific Advisory Board with Key Appointments

World-Renowned Plant-Biochemistry Experts Named to Calyxt's Scientific Advisory Board Chaired by Company Co-Founder Dan Voytas, Ph.D.

Feb 23, 2021 08:31 am ET

Calyxt Announces High Oleic Soybean Seed Sales Agreement with Perdue AgriBusiness

Calyxt Secures its First Seed Distribution Agreement Since Advancing Business Model

Feb 19, 2021 04:05 pm ET

Calyxt Announces Dr. Yves Ribeill Appointed As Executive Chair Replacing CEO Jim Blome

ROSEVILLE, MN / ACCESSWIRE / February 19, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a plant-based technology company, today announced that the Board of Directors has appointed Yves Ribeill, Ph.D., to the new role of Executive Chair of the Board effective immediately. Dr. Ribeill will serve in this role while Calyxt initiates a search for a new Chief Executive Officer to replace Jim Blome, who is leaving to pursue other opportunities. Calyxt has retained a premier executive search firm to lead the search. Based on his long experience in the biotech and i

Feb 09, 2021 08:31 am ET

Calyxt to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, March 4, 2021 at 4:30 p.m. Eastern Time

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, March 4, 2021 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2020. A press release detailing these results will be issued prior to the call.

Dec 14, 2020 08:31 am ET

Calyxt Announces Sale of Entire 2020 Grain Production to ADM

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has contracted to sell all 2020 grain production of its high oleic soybean to ADM (NYSE: ADM), a global leader in human and animal nutrition and the world’s premier agricultural origination and processing company headquartered in Chicago. The transaction is a key step

Nov 11, 2020 08:31 am ET

Calyxt Announces Collaboration with NRGene® to Advance its Product Pipeline

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, today announced a research collaboration with NRGene® that i

Nov 05, 2020 04:05 pm ET

Calyxt Reports Third Quarter 2020 Financial Results

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the third quarter ended September 30, 2020.

Nov 02, 2020 08:00 am ET

S&W Seed Company Announces Commercial Agreement with Calyxt Inc. to Deliver Improved Quality Alfalfa

LONGMONT, Colo., Nov. 2, 2020 /PRNewswire/ -- S&W Seed Company (NASDAQ: SANW), a global agricultural company headquartered in Longmont, Colorado announced today that it has agreed to commercial terms with Calyxt, Inc. (NASDAQ: CLXT) headquartered in Roseville, MN for the exclusive license of an improved quality alfalfa seed in the U.S. and other select geographies.

Oct 29, 2020 08:31 am ET

Calyxt Announces Commercial Agreement with S&W Seed Company to Deliver Improved Quality Alfalfa

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has agreed to commercial terms with S&W Seed Company (Nasdaq:

Oct 27, 2020 08:31 am ET

Calyxt to Host Virtual Analyst Day on Tuesday, November 17, 2020 at 4:00 p.m. Eastern Time

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will host a Virtual Analyst Day on Tuesday, November 17, 2020 at 4:00 p.m. Eastern time.

Oct 20, 2020 04:01 pm ET

Calyxt Announces Closing of Registered Direct Offering of Common Stock

Calyxt, Inc. (NASDAQ: CLXT) (the “Company”), a plant-based technology company, today announced the closing of its previously announced registered direct offering of 3,750,000 shares of the Company’s common stock, at a purchase price of $4.00 per share. Cellectis S.A., the Company’s majority shareholder, purchased 1,250,000 shares in the offering.

Oct 16, 2020 08:15 am ET

Calyxt Announces $15 Million Registered Direct Offering

Calyxt, Inc. (NASDAQ: CLXT) (the “Company”), a plant-based technology company, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of 3,750,000 shares of the Company’s common stock, at a purchase price of $4.00 per share, in a registered direct offering. Cellectis S.A., the Company’s major

Oct 14, 2020 04:01 pm ET

Calyxt Appoints Sarah Reiter as Vice President of Business Development

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has appointed Sarah Reiter as Vice President, Business Development. In this role, Ms. Reiter will drive new business opportunities at Calyxt to support the company’s recently announced go-to-market strategies.

Oct 13, 2020 08:31 am ET

Calyxt to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, November 5, 2020 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2020. A press release detailing these results will be issued prior to the call.

Aug 31, 2020 05:00 pm ET

LD Micro 360 Companies Set to Present this Week

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

Aug 25, 2020 08:31 am ET

Calyxt to Present at Upcoming September Investor Conferences

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will participate in the following investor conferences during the month of September 2020: the LD 500 Virtual Investor Conference on September 1-4, 2020, and the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 2020.

Aug 17, 2020 02:55 pm ET

Proactive Virtual Event Brings Together a Quartet of Innovative Growth Companies

Proactive, the digital financial news organization, will be showcasing four leading-edge tech, online gaming and biopharma businesses via its North American virtual investor conference. The event will feature live webcast presentations from the...

Aug 05, 2020 04:55 pm ET

Calyxt Reports Second Quarter 2020 Financial Results

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the second quarter ended June 30, 2020.

Aug 05, 2020 09:00 am ET

LD Micro - Announces Preliminary List of Presenters for the LD-500

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

Aug 05, 2020 09:00 am ET

LD Micro Announces Preliminary List of Presenters for the LD 500

Aug 03, 2020 08:31 am ET

Calyxt to Present at the Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will present at the Canaccord Genuity 40th Annual Growth Conference. The event is being held virtually and will take place on August 11 to 13, 2020.

Jul 20, 2020 08:31 am ET

Calyxt to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020 at 8:00 a.m. Eastern Time

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, August 6, 2020 at 8:00 a.m. Eastern time to discuss its results for the second quarter ended June 30, 2020. A press release detailing these results will be issued prior to the call.

Jul 06, 2020 06:10 pm ET

Calyxt Announces Board Changes

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced the appointment of current board member Yves Ribeill, Ph.D., as Chairman. This appointment coincides with Dr. André Choulika's decision to wholly focus his energy on Cellectis’ clinical development activities, and thus, retiring as Chairman of Calyxt’s Board. Additionally, Calyxt’s

Jun 03, 2020 08:31 am ET

Calyxt’s High Oleic Low Linolenic Soybean Oil Deemed Non-Regulated by USDA

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that its high oleic low linolenic (HOLL) soybean has been deemed a non-regulated article under the “Am I Regulated?” process by Biotechnology Regulatory Services of the Animal and Plant Health Inspection Service (APHIS), an agency of the United Sta

May 07, 2020 08:01 am ET

Calyxt Reports First Quarter 2020 Financial Results

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the first quarter ended March 31, 2020.

Apr 30, 2020 08:31 am ET

Calyxt Launches Consumer E-Commerce Channel for Calyno® Premium Cooking Oil

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has launched a retail offering of Calyno® cooking oil, the company’s first commercial product, a premium, high-performing oil, through the company’s newly launched e-commerce website

Apr 14, 2020 08:31 am ET

Calyxt to Host First Quarter 2020 Financial Results Conference Call on Thursday, May 7, 2020 at 8:30 a.m. Eastern Time

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, May 7, 2020 at 8:30 a.m. Eastern time to discuss its results for the first quarter ended March 31, 2020. A press release detailing the first quarter 2020 results will be issued prior to the call.

Apr 07, 2020 08:31 am ET

Calyxt Licenses New Enabling Technology from University of Minnesota for Greater Efficiency in Gene Edited Plants

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has licensed a new method to help increase plant gene editing efficiency from the University of Minnesota. The method has the potential to reduce the time needed to edit plants from approximately one year to several months.

Mar 24, 2020 08:31 am ET

Calyxt Launches New Website Showcasing the Power and Possibilities of Plants

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has launched its new website to showcase how Calyxt is harnessing the ‘Power and Possibilities of Plants’.

Mar 05, 2020 07:15 am ET

Calyxt Reports Record Fourth Quarter and Full Year 2019 Financial Results

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the fourth quarter and full year ended December 31, 2019.

Feb 10, 2020 08:31 am ET

Calyxt to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call on Thursday, March 5, 2020 at 8:30 a.m. Eastern Time

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, March 5, 2020 at 8:30 a.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2019. A press release detailing these results will be issued prior to the call.

Feb 07, 2020 08:31 am ET

Calyxt Achieves 2020 Soybean Contracted Acreage Goal of 100,000 Acres

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has achieved its 2020 contracted acreage target, successfully contracting 100,000 soybean acres with U.S. farmers.

Jan 23, 2020 09:00 am ET

Calyxt Appoints Bobby Williams as Gene Editing Director to Expand Innovation and Product Pipeline

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has appointed Bobby Williams, Ph.D. to the newly created role of Director of Gene Editing to further expand Calyxt’s innovation, product pipeline, and trait discovery efforts and inform product advancement decisions.

Jan 21, 2020 08:31 am ET

Calyxt Issues Stockholder Letter

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has released the following letter to its stockholders from Jim Blome, Chief Executive Officer.

Dec 16, 2019 08:31 am ET

Calyxt Announces Collaboration with Central Valley Ag to Expand Grower Network

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has entered into a collaboration with

Dec 03, 2019 08:31 am ET

Calyxt Appoints Vince Restucci as Vice President of Agronomy Services to Accelerate Expansion

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has appointed Vince Restucci in a newly created role as Vice President of Agronomy Services to support the expansion of Calyxt’s grower network and Identity Preserved System.

Nov 12, 2019 01:00 pm ET

Calyxt to Participate at Upcoming Investor Conferences

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has been invited to participate in the following investor conferences during the months of November and December 2019:

Nov 06, 2019 04:05 pm ET

Calyxt Reports Record Third Quarter 2019 Financial Results

Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company focused on healthy food ingredients, has reported results for its third quarter ended September 30, 2019.

Oct 30, 2019 08:18 am ET

Calyxt to Host Third Quarter 2019 Results Conference Call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern Time

Calyxt, Inc. (NASDAQ: CLXT), a plant-based breeding and technology platform company, will hold a conference call on Wednesday, November 6, 2019 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2019. A press release detailing these results will be issued prior to the call.

Sep 26, 2019 09:01 am ET

Calyxt Provides Business and R&D Pipeline Update at Wells Fargo Consumer Conference

Calyxt, Inc. (NASDAQ: CLXT), a healthy food innovation company, today provided a business update, announced its expanded R&D pipeline, and discussed R&D exploration activities.

Sep 19, 2019 04:38 pm ET

Calyxt® Announces Seed Agreement with Landus Cooperative

Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredients company, today announced that the Company has expanded its geographic footprint for acreage growth and weather-risk diversity by adding Landus Cooperative’s seed distribution, agronomy support, grain storage, and transportation services for Calyxt high oleic soybeans.

Sep 11, 2019 09:12 am ET

Calyxt® to Present at the Fall Investor Summit on September 17, 2019

Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredient company, today announced that management plans to present at the Fall Investor Summit in New York City.

Sep 03, 2019 05:59 pm ET

Calyxt Strengthens its Leadership Team to Support Commercial Growth Opportunities

Calyxt, Inc. (NASDAQ: CLXT) a healthy food ingredients company, today announced that the Company is expanding its leadership team to support commercial growth opportunities.

Aug 06, 2019 08:45 pm ET

Calyxt Reports 2nd Quarter Financial Results

Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredients company, today announced its results for the second quarter ended June 30, 2019.

Jul 22, 2019 06:20 pm ET

Calyxt to Hold Second Quarter Investor Conference Call on Wednesday, August 7, at 8:30 a.m. EDT – 7:30 a.m. CDT

Calyxt, Inc. (NASDAQ: CLXT) a healthy food ingredient company, today announced a conference call for investors to be held on Wednesday, August 7, 2019 at 8:30 a.m. EDT – 7:30 a.m. CDT. The call will include the company’s second quarter results.

Jun 25, 2019 09:27 am ET

Calyxt® Reiterates 2019 Guidance and Gives Business Update During June 25 Investor Day

Calyxt, Inc. (NASDAQ:CLXT), a healthy food ingredients company, will host an Investor & Analyst Day at the Company’s headquarters on Tuesday, June 25, 2019. During the event, the Company will reiterate its 2019 financial guidance and give a business update covering the following points:

Jun 24, 2019 04:30 pm ET

Calyxt® Enters Commercial Soybean Crushing Agreement with Landus Cooperative

Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredients company, today announced that it has entered into a commercial crushing agreement with Landus Cooperative, significantly expanding Calyxt’s network of processing partners. With this agreement, Landus Cooperative, with decades of soybean crushing experience, will manufacture, purchase and distribute soybean meal.

Jun 11, 2019 04:30 pm ET

Calyxt to Host Investor & Analyst Day on June 25, 2019

Calyxt, Inc. (NASDAQ:CLXT), a healthy food ingredients company, will host an Investor & Analyst Day at the Company’s headquarters on Tuesday, June 25, 2019 from noon – 5 p.m. CDT.

May 15, 2019 04:30 pm ET

Calyxt Appoints Dr. Travis Frey as Chief Technology Officer

Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredient company, announced today the appointment of Dr. Travis Frey as Chief Technology Officer, effective May 20, 2019. Dr. Frey brings his extensive knowledge in plant biology and biotechnology to a newly created position at the Company. As CTO, Dr. Frey will be responsible for the Re

May 07, 2019 05:30 pm ET

Calyxt Reports 1st Quarter Financial Results

Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredient company, today announced its results for the first quarter ended March 31, 2019.

May 06, 2019 04:30 pm ET

Dr. Dan Voytas, Co-Founder & Chief Science Officer of Calyxt, Elected to the National Academy of Sciences

Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredient company, announced today that its co-founder and Chief Science Officer, Dan Voytas, Ph.D., has been elected to the National Academy of Sciences (NAS) for his many contributions to the field of plant genomics, one of which is being an inventor of the TALEN® gene-editin

Apr 29, 2019 04:30 pm ET

Calyxt to Hold First Quarter Investor Conference Call on Wednesday, May 8, at 8:30 a.m. EDT – 7:30 a.m. CDT

Calyxt, Inc. (NASDAQ: CLXT) a healthy food ingredient company, today announced a conference call for investors to be held on Wednesday, May 8, 2019 at 8:30 a.m. EDT – 7:30 a.m. CDT. The call will include the company’s first quarter results.

Apr 11, 2019 07:15 am ET

Report: Developing Opportunities within Noble Energy, American Vanguard, Calyxt, Medallion Financial, iRadimed, and Stewart Information Services — Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Noble Energy Inc. (NYSE:NBL), American Vanguard Corporation (NYSE:AVD),...

Mar 11, 2019 04:10 pm ET

Calyxt Reports 4th Quarter and Full Year 2018 Financial Results

Calyxt, Inc. (NASDAQ:CLXT), a healthy food ingredient company, today announced its results for the fourth quarter and full year ended December 31, 2018.

Mar 05, 2019 04:30 pm ET

Calyxt to Hold Fourth Quarter and Full-Year 2018 Investor Conference Call on Tuesday, March 12, at 8:30 a.m. EDT – 7:30 a.m. CDT

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, today announced the company will hold a conference call for investors on Tuesday, March 12, 2019 at 8:30 a.m. EDT – 7:30 a.m. CDT. The call will include the company's fourth quarter 2018 and year-end financial results.

Feb 26, 2019 04:30 pm ET

First Commercial Sale of Calyxt High Oleic Soybean Oil on the U.S. Market

Calyxt, Inc. (NASDAQ:CLXT) a consumer-centric, food- and agriculture-focused Company, announced today the successful commercial launch of its highly anticipated Calyno™ High Oleic Soybean Oil, which is the Company’s first product to be sold on the U.S. market. This first commercial sale of Calyno oil is to the foodservice industry f

Feb 19, 2019 06:54 pm ET

Calyxt and Agtegra Cooperative Announce Strategic Collaboration to Distribute Calyxt High Oleic Soybean

Calyxt, Inc. (NASDAQ: CLXT) a consumer-centric, food and agriculture-focused Company, and Agtegra Cooperative (Agtegra) announced today that Agtegra will offer distribution, storage and transportation services for Calyxt High Oleic Soybean to its customers. Agtegra is an innovative farmer owned grain and agronomy cooperative serving

Feb 11, 2019 07:45 am ET

Consolidated Research: 2019 Summary Expectations for Granite Point Mortgage Trust, Brandywine Realty Trust, Kraton, Century Aluminum, Rudolph Technologies, and Calyxt — Fundamental Analysis, Key Perfo

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Granite Point Mortgage Trust Inc. (NYSE:GPMT), Brandywine Realty Trust...

Jan 28, 2019 04:30 pm ET

Calyxt Names Debra Frimerman as General Counsel

Calyxt, Inc. (NASDAQ: CLXT) a consumer-centric, food- and agriculture-focused Company, announced today the appointment of Debra Frimerman as General Counsel, effective February 11, 2019. Debra brings deep industry knowledge and legal expertise to the Calyxt executive team.

Jan 23, 2019 05:00 pm ET

Kimberly Nelson Appointed to Calyxt Board of Directors

Calyxt Inc. (NASDAQ: CLXT) a consumer-centric, food- and agriculture-focused Company, announced today that Kimberly Nelson has been appointed to its Board of Directors, effective January 17, 2019.

Jan 22, 2019 05:30 pm ET

Calyxt Doubles 2018 High Oleic Soybean Acres

Calyxt, Inc. (NASDAQ: CLXT) a consumer-centric, food- and agriculture-focused company, announced today that it has contracted over 34,000 acres of its High Oleic Soybean with more than 100 farmers in the upper Midwest region including South Dakota, Minnesota, Iowa and Nebraska. With this number of acres secured for 2019, the company

Jan 03, 2019 04:30 pm ET

Calyxt Appoints Veteran Finance Executive, William F. Koschak, as Chief Financial Officer

Calyxt, Inc. (NASDAQ: CLXT) a consumer-centric, food- and agriculture-focused Company, announced today the hiring of William F. (Bill) Koschak, as Chief Financial Officer of Calyxt, effective January 7, 2019. Mr. Koschak will be assuming the responsibilities of current interim CFO, Eric Dutang, who remains CFO of Cellectis, Calyxt’s

Dec 17, 2018 04:30 pm ET

Calyxt Receives EU Patent on Use of CRISPR/Cas9 for Genome Editing in Plants

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, today announced the issuance of European patent No. 3008186, which claims methods to create gene-edited plants by the transient delivery of sequence-specific nucleases, including CRISPR/Cas9. This patent, granted by the European Patent Office, is

Nov 26, 2018 08:55 am ET

Report: Exploring Fundamental Drivers Behind Reata Pharmaceuticals, Calyxt, SIFCO Industries, EchoStar, Tel-Instrument Electronics, and United States Antimony — New Horizons, Emerging Trends, and Upco

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Reata Pharmaceuticals, Inc. (NASDAQ:RETA), Calyxt, Inc. (NASDAQ:CLXT),...

Nov 13, 2018 04:30 pm ET

Calyxt Reports Financial Results for Third Quarter 2018

Calyxt, Inc. (NASDAQ:CLXT), a consumer-centric, food- and agriculture-focused company, today announced its results for the three- and nine-month periods ended September 30, 2018.

Nov 05, 2018 04:46 pm ET

Calyxt to Hold Third Quarter 2018 Investor Conference Call on Wednesday, November 14, at 8 a.m. EST – 7 a.m. CST

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, today announced the company will report financial results for the third quarter of 2018 on Tuesday, November 13, after the close of regular stock market trading hours. A conference call to discuss the company's results and its operations is schedu

Oct 15, 2018 04:30 pm ET

Calyxt Hires Former Cargill Supply Chain Manager

Calyxt, Inc. (Nasdaq: CLXT), a consumer-centric, food- and agriculture-focused Company, announced today that Aaron Snyder has joined the Calyxt team as a supply chain manager, effective October 15, 2018. Mr. Snyder will be responsible for procuring all materials that are needed for production, as well as overseeing shipping operations, implementing and managing new planning processes.

Oct 10, 2018 04:30 pm ET

Calyxt Harvests High-Fiber Wheat Field Trials

Calyxt, Inc. (NASDAQ:CLXT), a consumer-centric, food- and agriculture-focused company, today announced that the Company has completed the inaugural harvest of its high-fiber wheat product, the world’s first gene-edited, consumer-focused wheat product. The high-fiber wheat product is already the seventh Calyxt product that has

Oct 09, 2018 07:45 am ET

Consolidated Research: 2018 Summary Expectations for LaSalle Hotel Properties, EchoStar, Clean Energy Fuels, Innophos, Data I/O, and Calyxt — Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of LaSalle Hotel Properties (NYSE:LHO), EchoStar Corporation (NASDAQ:SATS),...

Oct 04, 2018 04:30 pm ET

Calyxt Inks Agreement with KemX Global to Refine High-Oleic Soybean Oil

Calyxt, Inc. (Nasdaq: CLXT), a consumer-centric, food- and agriculture-focused company, announced today that the Company has inked an agreement with KemX Global, a leading provider of innovative organic processing of oils, to refine Calyxt’s high-oleic soybean oil – an advancement that will allow Calyxt to produce food-grade high-oleic soybean oil as the Company’s first product that is expected to hit the market in late 2018/ early 2019.

Sep 27, 2018 04:30 pm ET

Calyxt Signs Agreement with American Natural Processors to Crush and Process its High-Oleic Soybeans

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused Company, announced today an agreement with American Natural Processors (ANP), a leading provider of innovative non-GMO and organic processing of oils, flours and meals, to crush Calyxt’s high-oleic soybean variety, and produce the Company’s high oleic soyb

Sep 18, 2018 04:30 pm ET

Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP

Regulatory News:

Sep 18, 2018 04:30 pm ET

Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP

Calyxt, Inc. (NASDAQ: CLXT) and Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) announced today the appointment of James A. Blome, former President and CEO of Bayer CropScience LP (North America), as Chief Executive Officer of Calyxt, effective October 1, 2018. Jim Blome will work closely with Calyxt’s Board of Directors to fo

Sep 17, 2018 04:30 pm ET

Christopher J. Neugent, a Leader of the Food Industry, Joins Calyxt Board of Directors

Calyxt, Inc. (NASDAQ: CLXT) announced today that Christopher J. Neugent, Executive Vice President of Strategy of Post Holdings, Inc. (NYSE: POST), joined its board of directors.

Aug 23, 2018 06:30 pm ET

Calyxt to Present at Wells Fargo Securities Agribusiness Panel

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, today announced that the Company will be participating in a roundtable discussion and presentation at the Wells Fargo Securities Agribusiness Panel held at the Hilton Garden Inn Urbandale, 8600 Northpark Drive, Johnston, IA, on Monday, A

Aug 22, 2018 08:00 am ET

Calyxt Names Biotech Veteran and Board of Directors Member Dr. Yves J. Ribeill as Interim CEO

Calyxt, Inc. (NASDAQ:CLXT) and Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) announced today its Board of Directors has appointed Yves Ribeill, Ph.D., as Interim Chief Executive Officer, effective immediately. Dr. Ribeill replaces Federico Tripodi, who is leaving the Company to pursue other opportunities. Currently a member

Aug 02, 2018 07:55 am ET

Factors of Influence in 2018, Key Indicators and Opportunity within MTS, First Financial Bankshares, Tribune Media, Calyxt, McGrath RentCorp, and NorthWestern — New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MTS Systems Corporation (NASDAQ:MTSC), First Financial Bankshares, Inc....

Aug 01, 2018 06:13 pm ET

Calyxt Reports Financial Results for Second Quarter and Half-Year 2018

Calyxt, Inc. (NASDAQ:CLXT), a consumer-centric, food- and agriculture-focused company, today announced its results for the three-month period and the first half period ended June 30, 2018.

Jul 30, 2018 07:30 am ET

Market Trends Toward New Normal in McDonald's, Calyxt, Ultra Petroleum, Crocs, The Progressive, and AmerisourceBergen — Emerging Consolidated Expectations, Analyst Ratings

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of McDonald's Corporation (NYSE:MCD), Calyxt, Inc. (NASDAQ:CLXT), Ultra...

Jul 19, 2018 08:00 am ET

Calyxt and S&W Seed Company Announce Milestone in Alfalfa Seed Development Program

Calyxt, Inc. (Nasdaq:CLXT), a consumer-centric, food- and agriculture-focused company, and S&W Seed Company (Nasdaq: SANW), a global leader in the alfalfa seed industry, today announced the successful transfer of their proprietary alfalfa seed and plants from the research and development facility at Calyxt to S&W for field evaluation and testing. This marks a significant milestone in the collaboration between the two companies.

May 23, 2018 07:30 am ET

Report: Developing Opportunities within MFA Financial, Stewart Information Services, Eagle Bulk Shipping, Monmouth Real Estate Investment, Granite Point Mortgage Trust, and Calyxt — Future Expectation

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MFA Financial, Inc. (NYSE:MFA), Stewart Information Services Corporation...

May 22, 2018 04:00 pm ET

Calyxt Announces Successful Closing of $60.9 Million Public Offering

Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) and Calyxt, Inc. (NASDAQ: CLXT) today announced the closing of Calyxt’s follow-on public offering of 4,057,500 shares of Calyxt’s common stock (inclusive of the full exercise by the underwriters of their option to purchase 457,500 additional shares) at a public offering price of $15.00 per share. The gross proceeds to Calyxt from the offering are approximately $60.9 million, before deducting the estimated expenses related to the offering and the underwriting discounts and commissions payable

May 21, 2018 08:30 am ET

Cellectis S.A.: Calyxt Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

Regulatory News:

May 15, 2018 05:50 pm ET

Calyxt Announces Launch of Proposed Follow-On Offering

Regulatory News:

May 15, 2018 04:41 pm ET

Bayer CropScience, LP Agrees to Settle Lawsuit Filed by Calyxt in Delaware Chancery Court

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, today announced that Bayer CropScience, LP (“Bayer”), has agreed to settle a lawsuit brought by Calyxt in the Delaware Chancery Court.

May 07, 2018 04:30 pm ET

Calyxt Reports Financial Results for First Quarter 2018

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, today announced its results for the three-month period ended March 31, 2018.

Apr 25, 2018 05:00 pm ET

Calyxt to Hold First Quarter 2018 Investor Conference Call on Tuesday, May 8, at 8 a.m. EDT – 7 a.m. CDT

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, today announced the company will report financial results for the first quarter of 2018 on Monday, May 7, after the close of regular stock market trading hours. A conference call to discuss the company's results and its operations is scheduled on

Apr 05, 2018 05:00 pm ET

Calyxt Exceeds Farmer Adoption Milestone for High-Oleic Soybean Product Launch

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, today announced that the Company has further expanded its total acreage with farmers across the northern United States for its high-oleic / no trans-fat soybean variety.

Mar 30, 2018 08:25 am ET

Consolidated Research: 2018 Summary Expectations for RadNet, Molecular Templates, Federated Investors, Kadant, Heartland Financial, and Calyxt — Fundamental Analysis, Key Performance Indications

NEW YORK, March 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of RadNet, Inc. (NASDAQ:RDNT), Molecular Templates Inc....

Mar 21, 2018 04:30 pm ET

Calyxt’s High Fiber Wheat Deemed Non-Regulated by USDA

Calyxt, Inc. (NASDAQ:CLXT), a consumer-centric, food- and agriculture-focused company, today announced that the Company’s high fiber wheat product has been declared a non-regulated article under the “Am I Regulated?” process by Biotechnology Regulatory Services of the Animal and Plant Health Inspection Service (APHIS), an agency of t

Mar 13, 2018 06:45 pm ET

Calyxt Reports Financial Results for Fourth Quarter and Full-Year 2017

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, today announced its results for the three-month period ended December 31, 2017 and for the year ended December 31, 2017.

Mar 12, 2018 08:34 pm ET

Calyxt Filed Complaint in Delaware Chancery Court Against Bayer CropScience, LP

Calyxt, Inc. (NASDAQ:CLXT), a consumer-centric, food- and agriculture-focused company, today announced that it has filed a complaint in Delaware Chancery Court against Bayer CropScience, LP (“Bayer”).

Mar 05, 2018 04:30 pm ET

Calyxt to Hold Fourth Quarter and Full-Year 2017 Investor Conference Call on Wednesday, March 14, at 8 a.m. EDT – 7 a.m. CDT

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, today announced the company will hold a conference call for investors on Wednesday, March 14, 2018 at 8 a.m. EDT – 7 a.m. CDT. The call will include the company's fourth quarter 2017 and year-end financial results.

Mar 01, 2018 08:00 am ET

Calyxt Expands Total Acreage with Farmers for High-Oleic Soybean Product

Calyxt, Inc. (NASDAQ:CLXT), a consumer-centric, food- and agriculture-focused company, today announced that the Company has expanded its total acreage with farmers across the United States for its high-oleic / no trans-fat soybean variety.

Jan 30, 2018 07:30 am ET

Consolidated Research: 2018 Summary Expectations for Immune Design, Primoris Services, Scotts Miracle-Gro, Heska, Calyxt, and Urstadt Biddle Properties — Fundamental Analysis, Key Performance Indicati

NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Immune Design Corp. (NASDAQ:IMDZ), Primoris Services...

Dec 12, 2017 04:30 pm ET

Calyxt and Farmer’s Business Network, Inc. Partner to Expand Grower Base for Calyxt’s Identity-Preserved High Oleic Soybeans

Calyxt, Inc. (NASDAQ: CLXT), a consumer-centric, food- and agriculture-focused company, and Farmer’s Business Network, Inc (FBNSM), the independent farmer-to-farmer network, today announced a partnership to expand the distribution and grower base of Calyxt’s identity-preserved high oleic soybeans in the upper Midwes

Nov 13, 2017 04:29 pm ET

Calyxt Reports Financial Results for Third Quarter and First Nine Months of 2017

Calyxt, Inc., (NASDAQ:CLXT) a consumer-centric, food- and agriculture-focused company, today announced its results for the three-month period ended September 30, 2017 and for the nine-month period ended September 30, 2017.

You are here

(:CLXT)

Business Focus: N/A